Clinical Social Workers in North Logan, UT Accepting Medicare
7 Clinical Social Workers found. Showing 1 - 7
 Dana Marie Jackson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 186 E 1800 N Ste 1, North Logan, UT 84341 Phone: 435-213-3026 |
Rachel White Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 50 E 2500 N Ste 104, North Logan, UT 84341 Phone: 435-213-1109 |
 Samuel Harris Pond, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2027 N 200 E, North Logan, UT 84341 Phone: 435-764-6312 |
Andrea Ellis Bott Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2072 N Main St Ste 205, North Logan, UT 84341 Phone: 435-213-1638 |
Leila Elmi-stuart, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 93 E 1600 N, North Logan, UT 84341 Phone: 435-279-6036 Fax: 435-753-9047 |
Heather Elizabeth Olsen, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 186 E 1800 N, North Logan, UT 84341 Phone: 435-754-9554 Fax: 435-752-1095 |
Nathan Mcclure Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2444 N 200 E, North Logan, UT 84341 Phone: 435-213-5722 |
News Archive
EC launches world's first in-flight smoking cessation card
The European Commission today announced a new phase in its highly successful smoking cessation campaign, "Ex-Smokers are Unstoppable" on World No Tobacco Day by launching the world's first in-flight smoking cessation card.
Dual-headed dedicated gamma camera accurately detects small breast tumors
A dual-headed dedicated gamma camera used during molecular breast imaging (MBI) can accurately detect small breast tumors less than 2 cm in size, according to a study performed at the Mayo Clinic in Rochester, MN.
No added benefit proven for pulmonary arterial hypertension drug, IQWiG finds
Selexipag is approved for long-term treatment of pulmonary arterial hypertension (PAH) in adults with moderate to severe symptoms.
Arrowhead increases ownership in Calando's outstanding equity to 79%
Arrowhead Research Corporation today announced that it has invested $1 million in its majority owned subsidiary, Calando Pharmaceuticals, and converted approximately $8M of Calando debt to Arrowhead into equity. Arrowhead now owns approximately 79% of Calando's outstanding equity.
› Verified 6 days ago
Dentists
Clinical Social Workers
Counselors
Pharmacists
Occupational Therapists